Mealey's (January 8, 2020, 12:43 PM EST) -- WASHINGTON, D.C. — A Delaware federal judge’s incorrect claim construction led to an erroneous finding of noninfringement, the Federal Circuit U.S. Court of Appeals held Jan. 7 in a win for patent owner Amgen Inc., maker of the drug “Sensipar” (Amgen Inc. v. Amneal Pharmaceuticals LLC, et al., Nos. 2018-2414, 2019-1086, Fed. Cir., 2020 U.S. App. LEXIS 245)....